Clinical Trials
4 trialsNCT02842125 2020-06-02
Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer
MultiVir, Inc.
Phase 1/2 Terminated
NCT00003147 2013-02-05
Gene Therapy in Treating Patients With Cancer of The Liver
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00017173 2012-06-14
S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat
SWOG Cancer Research Network
Phase 2 Terminated
NCT00410865 2011-12-07
Wild Type p53 Adenovirus for Oral Premalignancies
M.D. Anderson Cancer Center
Phase 1 Terminated